{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2655, 
        2669
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3564, 
        3587
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2746, 
        2754
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2299, 
        2326
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        527, 
        556
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2136, 
        2162
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2362, 
        2368
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2421, 
        2427
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2480, 
        2486
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2539, 
        2545
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2718, 
        2724
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2369, 
        2385
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2428, 
        2444
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2487, 
        2503
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2546, 
        2562
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2645, 
        2654
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2725, 
        2741
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2173, 
        2183
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2196, 
        2205
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2218, 
        2227
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2240, 
        2248
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2261, 
        2271
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2284, 
        2293
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2341, 
        2351
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2401, 
        2410
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2460, 
        2469
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2520, 
        2528
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2578, 
        2588
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2698, 
        2707
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2328, 
        2329
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2388, 
        2389
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2447, 
        2448
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2507, 
        2508
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2565, 
        2566
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2685, 
        2686
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 2^9999^MOH|PIMS|CCO-OCR|20160503161200|0042DFD04504A8D0141205796D4D206EFD293C51|ORU^R01|9999999999999999|P|2.5|\nPID|1||SA99999999^^^^CMR^HOSPITAL 2&9999&MOH~SA99999999^^^^MRN^HOSPITAL 2&9999&MOH~9999999999&CG&ON^^^^JHN||XXXXX^XXXXX||99999999|M||||||||||||||||||||||N|\nOBR|1||S16-24685|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604180945|||94738^XXXXXX^XXXXX||||201604181527|&Prostate:Right base bx|99999^XXXXXX^XXXXX||||||201605031612||S|F|||||||999999^XXXXXXXXX^XXXXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1. The specimen labeled with the patient's name and as \"right base x2 needle biopsy prostate\", consists of 2 core like pieces of tan tissue measuring from 1.5 to 1.7 cm in length x 0.1 cm in diameter, received in 10% buffered formalin.\n1A submitted in toto\n\n\n2. The specimen labeled with the patient's name and as \"left base x2 needle biopsy prostate\", consists of 2 core like pieces of tan tissue measuring from 1.5 to 1.8 cm in length x 0.1 cm in diameter, received in 10% buffered formalin.\n2A submitted in toto\n\n3. The specimen labeled with the patient's name and as \"right mid x2 needle biopsy prostate\", consists of 2 core like pieces of tan tissue measuring from 1.1 to 1.9 cm in length x 0.1 cm in diameter, received in 10% buffered formalin.\n3A submitted in toto\n\n4. The specimen labeled with the patient's name and as \"left mid x2 needle biopsy prostate\", consists of 3 core like pieces of tan tissue measuring from 0.5 to 1.7 cm in length x 0.1 cm in diameter, received fragmented in 10% buffered formalin.\n4A submitted in toto\n\n5. The specimen labeled with the patient's name and as \"right apex x2 needle biopsy prostate\", consists of 3 core like pieces of tan tissue measuring from 0.1 to 1.9 cm in length x 0.1 cm in diameter, received fragmented in 10% buffered formalin.\n5A submitted in toto\n\n6.The specimen labeled with the patient's name and as \"left apex x2 needle biopsy prostate\", consists of 3 core like pieces of tan tissue measuring from 0.4 to 1.1 cm in length x 0.1 cm in diameter, received fragmented in 10% buffered formalin.\n6A submitted in toto\n\n\n\nPath report.site of origin\n\nProstate:Right base bx\nProstate:Left base bx\nProstate:Right mid bx\nProstate:Left mid bx\nProstate:Right apex bx\nProstate:Left apex bx\n\n\nPath report.final diagnosis\n\n1. Prostate, right base, biopsy:\n-benign prostatic tissue.\n\n2. Prostate, left base, biopsy:\n-benign prostatic tissue.\n\n3. Prostate, right mid, biopsy:\n-benign prostatic tissue. \n\n4. Prostate, left mid, biopsy:\n-benign prostatic tissue.\n\n5. Prostate, right apex, biopsy:\n-small focus of atypical glands suspicious for prostatic adenocarcinoma, see comment.\n\n6. Prostate, left apex, biopsy:\n-benign prostatic tissue. \n\n\nComment: In part 5, right apex biopsy, there are 5-6 small, crowded glands occupying <0.25 mm of the microscopic field, that have irregular nuclear membranes and occasional nucleoli.This focus is adjacent to a larger branching duct that focally shows nucleoli as well. By immunohistochemistry this small focus is negative for basal cell marker prostate cocktail (P63/HMWK) and is positive for AMACR while the surrounding glands show the opposite immuno profile. The immunohistochemistry is supportive of an adenocarcinoma, however, the morphology of this focus may represent a benign process such as an outpouching of adjacent glands tangentially sectioned, or adenosis of the prostate glands. The overall findings are suspicious, but not definitive for adenocarcinoma, in this very small focus of atypical glands.\n\n\n\nPath report.relevant Hx\n\nR/O prostate cancer.\n\n\n\n"
}